Mini-hyper-CVD plus inotuzumab ozogamicin, with or without blinatumomab, in the subgroup of older patients with newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: long-term results of an open-label phase 2 trial
Titel:
Mini-hyper-CVD plus inotuzumab ozogamicin, with or without blinatumomab, in the subgroup of older patients with newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: long-term results of an open-label phase 2 trial
Auteur:
Jabbour, Elias Short, Nicholas J Senapati, Jayastu Jain, Nitin Huang, Xuelin Daver, Naval DiNardo, Courtney D Pemmaraju, Naveen Wierda, William Garcia-Manero, Guillermo Montalban Bravo, Guillermo Sasaki, Koji Kadia, Tapan M Khoury, Joseph Wang, Sa A Haddad, Fadi G Jacob, Jovitta Garris, Rebecca Ravandi, Farhad Kantarjian, Hagop M